INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Logitech International S.A. – LOGI

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Logitech International S.A. ("Logitech" or the "Company") (NASDAQ:LOGI). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Logitech and certain of its officers and/or […]

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trex Company, Inc. – TREX

NEW YORK, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Trex Company, Inc. ("Trex" or the "Company") (NYSE:TREX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Trex and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. – SLNO

NEW YORK, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Soleno Therapeutics, Inc. ("Soleno" or the "Company") (NASDAQ:SLNO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Soleno and certain of its officers and/or directors

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Enovix Corporation – ENVX

NEW YORK, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Enovix Corporation ("Enovix" or the "Company") (NASDAQ:ENVX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Enovix and certain of its officers and/or directors have

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. – AVXL

NEW YORK CITY, NY / ACCESS Newswire / December 14, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Anavex and certain of its officers

Employment & Labor Layers, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, File Suit Against JT4, LLC, for Alleged Failure to Provide Employees with Required Meal Breaks

Engineering and technical support company, JT4, LLC allegedly required employees to work while clocking out during what is supposed to be an employee's off-duty meal break. This may have resulted in missed wages for employees. **THIS IS AN ATTORNEY ADVERTISEMENT** The San Francisco employment law attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, filed a

EVDANCE Expands 2025 Home Charging Guidance with In-Depth Recommendations for Certified Level-1 and Level-2 Portable EV Chargers

NEW YORK, Dec. 14, 2025 (GLOBE NEWSWIRE) — As electric vehicle ownership becomes more mainstream, homeowners and renters alike face a growing need for safe, flexible, and certified home-charging solutions. EVDANCE today publishes an expanded set of product recommendations and technical guidance for consumers considering portable Level-1 and Level-2 chargers. The guidance highlights UL2594-tested safety,

EVDANCE Expands 2025 Home Charging Guidance with In-Depth Recommendations for Certified Level-1 and Level-2 Portable EV Chargers

EVDANCE Expands 2025 Home Charging Guidance with In-Depth Recommendations for Certified Level-1 and Level-2 Portable EV Chargers GlobeNewswire December 14, 2025 NEW YORK, Dec. 14, 2025 (GLOBE NEWSWIRE) — As electric vehicle ownership becomes more mainstream, homeowners and renters alike face a growing need for safe, flexible, and certified home-charging solutions. EVDANCE today publishes an

INSPIRE MEDICAL SYSTEMS DEADLINE: ROSEN, LEADING TRIAL ATTORNEYS, Encourages Inspire Medical Systems, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – INSP

New York, New York–(Newsfile Corp. – December 14, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the “Class Period”), of the important January 5, 2026 lead plaintiff deadline. SO

Scroll to Top